Research Papers

A curated document list highlighting the utility and performance of LiverMultiScan

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Understanding complexity

Associations between MRI T1 mapping, liver stiffness, quantitative MRCP, and laboratory biomarkers in children and young adults with autoimmune liver disease.

Read more
Understanding complexity

Longitudinal Changes in Quantitative Magnetic Resonance Imaging Metrics in Children and Young Adults with Autoimmune Liver Disease

Read more
Validation studies

Reference range of liver corrected T1 values in a population at low risk for fatty liver disease—a UK Biobank sub-study, with an appendix of interesting cases

Read more
Validation studies

Clinical utility of MRI biomarkers for identifying NASH patients at high risk of progression: A multi-center pooled data and meta-analysis

Read more
Making patients better

Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease

Read more
Understanding complexity

Quantitative multiparametric MRI as a non-invasive stratification tool in children and adolescents with autoimmune liver disease

Read more
Validation studies

Quantitative multiparametric MRI can aid NASH diagnosis in a Japanese cohort

Read more
Validation studies

Correlations between MRI biomarkers PDFF and cT1 with histopathological features of non-alcoholic steatohepatitis

Read more
Predicting outcomes

Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver disease

Read more
Making patients better

NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis

Read more
Validation studies

Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease

Read more
Validation studies

Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease

Read more
Understanding complexity

Quantitative magnetic resonance imaging to aid clinical decision making in autoimmune hepatitis

Read more
Making patients better

Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH

Read more
Predicting outcomes

Multiparametric magnetic resonance imaging for the assessment of nonalcoholic fatty liver disease severity

Read more
Predicting outcomes

Liver disease is a significant risk factor for cardiovascular outcomes

Read more
Making patients better

Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis

Read more
Making patients better

A low energy totel diet replacement program demonstrates a favorable safety profile and improves liver disease severity in nonalcoholic steatohepatitis

Read more
Understanding complexity

Novel multimetric MRI detects improved future liver remnant quality post-dual vein embolization

Read more
Validation studies

Decreases in cT1 and liver fat content reflect histological improvement induced by therapies in MASH: a multicentre pooled cohort analysis

Read more
Validation studies

Quantitative MRI for monitoring metabolic dysfunction associated steatotic liver disease: A test-retest repeatability study

Read more
Understanding complexity

Feasibility of using contrast-free quantitative magnetic resonance imaging for liver sparing stereotactic ablative body radiotherapy

Read more
Making patients better

MRI-serum–based score accurately identifies patients undergoing liver transplant without rejection avoiding the need for liver biopsy: A multisite European study

Read more
Understanding complexity

Corrected T1 Mapping in Children and Young Adults With Autoimmune Liver Disease: Correlation With Histology

Read more
Understanding complexity

Diagnosis and management of autoimmune hepatitis

Read more
Full publication list